Venue and hours

Maritim proArte Hotel Venue

Maritim proArte Hotel
Friedrichstraße 151
10117 Berlin



Discover the 3 patient phenotypes

Discover 3 typical patient phenotypes: these hypertensive patients presenting with different symptoms (heart failure, atrial fibrillation and renal insufficiency) will be discussed throughout Course sessions. This week, Patient #3 with renal insufficiency is revealed!

New case on PCRonline

"Percutaneous renal denervation in a drug-naive patient with multiple intolerances to antihypertensive agents reduced office and ambulatory blood pressure" Discover this new case and say how you would treat.

3 patient phenotypes

The special focus of this year’s event will be the identification and prevention of Target Organ Damage. 3 typical patients will be discussed during Course sessions. These hypertensive patients are presenting with different symptoms: heart failure, atrial fibrillation and chronic kidney disease.


Discover more about Patient #1 on 17th January, Patient #2 on 24th January and Patient #3 on 31st January.

Atul Pathak shares his thoughts about the resistant hypertension topic discussed during EuroPCR 2014

Andrzej Januszewicz on Obstructive Sleep Apnea

Andrzej Januszewicz (Poland) answers the following questions:

- Do you screen every hypertensive patient for obstructive sleep apnea and why or why not?
- What are possible treatment options for patients with obstructive sleep apnea?

Peter Blankestijn on Blood Pressure Measurement

Peter J. Blankestijn (Netherlands) answers the following questions:

- Can you please explain the different modalities in measuring blood pressure, and the differences between home-based, office-based and ambulatory blood pressures?
- What are your requirements for valid blood pressure measurement?
- How often should blood pressure be measured by the patient?
- What are your thoughts and recommendations with regards to automatic vs. manual blood pressure measurement?


Results from the Global SYMPLICITY Registry presented at ACC 2014

Michael Böhm (University of Saarland, Homburg/Saar, Germany) co-chairman of the Global SYMPLICITY Registry presented today during the late-breaking clinical trial session at the 63rd Scientific Sessions of the American College of Cardiology (ACC) the six month analysis of the first 1,000 patients enrolled in the open-label real-world patient registry. The Global SYMPLICITY Registry continues to demonstrate the safety of renal denervation with the Symplicity™ renal denervation system.